Novel Inhibitors of Inosine Monophosphate Dehydrogenase as Potential Anti-Cancer Drugs: A Patent Review (2002-2014)
- Authors: Riccardo Petrelli1, Ilaria Torquati2, Krzysztof Felczak3, Daniel J. Wilson4, Loredana Cappellacci5
-
View Affiliations Hide Affiliations1 School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino, Italy 2 School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino, Italy 3 Center for Drug Design, University of Minnesota, Minneapolis, MN 55455, USA 4 Center for Drug Design, University of Minnesota, Minneapolis, MN 55455, USA 5 School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino, Italy
- Source: Topics in Anti-Cancer Research: Volume 3 , pp 37-102
- Publication Date: October 2014
- Language: English
Novel Inhibitors of Inosine Monophosphate Dehydrogenase as Potential Anti-Cancer Drugs: A Patent Review (2002-2014), Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9781608059089/chapter-2-1.gif
Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme that controls de novo synthesis of guanine nucleotides, has received considerable interest in recent years as an important target enzyme, not only for the discovery of anticancer drugs, but also for antiviral, antiparasitic, and immunosuppressive chemotherapy. The field of IMPDH inhibitor research is highly important for providing potential therapeutics against a validated target for disease intervention. This patent chapter examines the chemical structures and biological activities of recently reported IMPDH inhibitors. Patent databases SciFinder and Espacenet and Delphion were used to locate patent applications that were published between January 2002 and November 2013, claiming chemical structures for use as IMPDH inhibitors. From 2002 to 2014, around 64 primary patent applications have claimed IMPDH inhibitors, which we analyzed by target and applicant. The level of newly published patent applications covering IMPDH inhibitors remains high and a diverse range of scaffolds has been claimed.
-
From This Site
/content/books/9781608059089.chapter-2dcterms_subject,pub_keyword-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData105
